Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2010 Nov;5(11):2060-8.
doi: 10.2215/CJN.00240110. Epub 2010 Aug 5.

A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis

Andrew Smyth  1 , Guilherme H M Oliveira, Brian D Lahr, Kent R Bailey, Suzanne M Norby, Vesna D Garovic
Affiliations
Meta-Analysis

A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis

Andrew Smyth et al. Clin J Am Soc Nephrol. 2010 Nov.

Abstract

Background and objectives: Studies of the impact of systemic lupus erythematosus (SLE) and its pregnancy complications have yielded conflicting results. Major limitations of these studies relate to their small numbers of patients and retrospective designs. The aim of this study was to perform a systematic literature review of pregnancy outcomes in women with SLE and a meta-analysis of the association of lupus nephritis with adverse pregnancy outcomes.

Design, setting, participants, & measurements: We searched electronic databases from 1980 to 2009 and reviewed papers with validity criteria. Random-effects analytical methods were used to evaluate pregnancy complications rates.

Results: Thirty-seven studies with 1842 patients and 2751 pregnancies were included. Maternal complications included lupus flare (25.6%), hypertension (16.3%), nephritis (16.1%), pre-eclampsia (7.6%), and eclampsia (0.8%). The induced abortion rate was 5.9%, and when excluded, fetal complications included spontaneous abortion (16.0%), stillbirth (3.6%), neonatal deaths (2.5%), and intrauterine growth retardation (12.7%). The unsuccessful pregnancy rate was 23.4%, and the premature birth rate was 39.4%. Meta-regression analysis showed statistically significant positive associations between premature birth rate and active nephritis and increased hypertension rates in subjects with active nephritis or a history of nephritis. History of nephritis was also associated with pre-eclampsia. Anti-phospholipid antibodies were associated with hypertension, premature birth, and an increased rate of induced abortion.

Conclusions: In patients with SLE, both lupus nephritis and anti-phospholipid antibodies increase the risks for maternal hypertension and premature births. The presented evidence further supports timing of pregnancy relative to SLE activity and multispecialty care of these patients.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flow diagram of studies assessed and used in this meta-analysis.
See this image and copyright information in PMC

References

    1. Cox JB: Disseminated lupus erythematosus in pregnancy. Obstet Gynecol 26: 511–514, 1965 - PubMed
    1. Bear R: Pregnancy and lupus nephritis. A detailed report of six cases with a review of the literature. Obstet Gynecol 47: 715–718, 1976 - PubMed
    1. Le Thi Huong D, Wechsler B, Piette JC, Bletry O, Godeau P: Pregnancy and its outcome in systemic lupus erythematosus. Q J Med 87: 721–729, 1994 - PubMed
    1. Wong CH, Chen TL, Lee CS, Lin CJ, Chen CP: Outcome of pregnancy in patients with systemic lupus erythematosus. Taiwan J Obstet Gynecol 45: 120–123, 2006 - PubMed
    1. Derksen RH, Bruinse HW, de Groot PG, Kater L: Pregnancy in systemic lupus erythematosus: A prospective study. Lupus 3: 149–155, 1994 - PubMed

Publication types

MeSH terms

Substances